Status:

COMPLETED

Endomicroscopy in Primary Sclerosing Cholangitis Related Inflammatory Bowel Disease Surveillance

Lead Sponsor:

Karolinska University Hospital

Conditions:

Primary Sclerosing Cholangitis

Inflammatory Bowel Disease

Eligibility:

All Genders

18-75 years

Brief Summary

Evaluation of the efficacy of laser-based endomicroscopy as a complement to white-light colonoscopy and chromoendoscopy for early detection of colon dysplasia in patients with PSC-IBD. White-light col...

Detailed Description

Chromoendoscopy by applying a dye (indigo-carmine) through the colonoscop is the new standard for cancer surveillance in patients with IBD . It gives the opportunity to identify suspected areas of dys...

Eligibility Criteria

Inclusion

  • clinical diagnosis of PSC-IBD

Exclusion

  • the lack of informed consent, allergy to fluorescein, B-blockers treatment

Key Trial Info

Start Date :

August 1 2011

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 1 2014

Estimated Enrollment :

69 Patients enrolled

Trial Details

Trial ID

NCT01880606

Start Date

August 1 2011

End Date

June 1 2014

Last Update

April 27 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Gastro Center Karolinska University Hospital

Stockholm, Sweden, 14186